EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 21-May-2026 09:16 ET (21-May-2026 13:16 GMT/UTC)

Wild flatworms heal wounds

Lund University
Peer-Reviewed Publication

Researchers from Lund University in Sweden collected wild flatworms from Malmö’s largest park, Pildammsparken. These creatures are masters at regenerating after injury. Now, for the first time, the worms’ unique ability to regenerate has been harnessed to help accelerate wound healing in human skin models.

Journal: ACS Omega
Funder: The Swedish Research Council, The Crafoord Foundation, The Carl Trygger Foundation,, The Gyllenstierna Krapperup Foundation, The Magnus Bergvall Foundation

Age, sex, and cancer type influence risk of subsequent cancers among survivors

PLOS
Peer-Reviewed Publication

Risk of developing a subsequent primary cancer varied significantly by age at initial diagnosis, sex, and type of first cancer, according to a study by Oxana Palesh and Susan Hong and colleagues at Virginia Commonwealth University, U.S., published April 28^th in the open-access journal PLOS Medicine.

Journal: PLOS Medicine

Researchers spot shifts in firearm suicide risk and seeking treatment after 2020 purchasing surge

Rutgers University
Peer-Reviewed Publication

Individuals who died by firearm suicide following the 2020 firearm purchasing surge were more likely to be from racial minority groups, had higher rates of suicidal ideation and were less likely to have engaged in mental health treatment prior to their death, according to Rutgers University researchers.

Journal: Suicide and Life-Threatening Behavior

Mayo Clinic study finds bariatric surgery associated with greater long-term heart risk reduction than weight-loss medications

Mayo Clinic
Peer-Reviewed Publication

A Mayo Clinic study found that both metabolic and bariatric surgery and GLP-1 medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk.

Journal: Annals of Surgery

Stopping and restarting certain GLP-1s to lose weight may make the drug less effective

University of Pennsylvania School of Medicine
Peer-Reviewed Publication

Inconsistent use of some GLP-1 weight-loss medications may significantly lessen their effectiveness, according to a new preclinical study.

Critical Path Institute awards $456,000 grant to advance next-generation therapy for rare glycolipid storage disorders

Critical Path Institute (C-Path)
Grant and Award Announcement

Critical Path Institute® today announced a $456,000 grant to James Shayman, M.D., at the University of Michigan, to support development of a brain-penetrant therapy for glycosphingolipid storage disorders. The award is part of C-Path’s Bridging Research and Innovation in Drug Development Grants (BRIDGe) program, offered through its Translational Therapeutics Accelerator.

New study finds link between difficulty identifying emotions and higher chronic pain levels

Johns Hopkins Medicine
Peer-Reviewed Publication

A large, two-year study led by researchers at Johns Hopkins Medicine and consisting of more than 1,400 adults living with chronic pain across the United States found that people who struggle to identify and describe their emotions experience greater disruption to daily life from pain over time due to increased psychological distress.

Journal: Health Psychology
Funder: Johns Hopkins Clinician Scientist Award

Targeted therapy drug shows early promise against KRAS-driven lung and pancreatic cancers

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of Medicine found that setidegrasib, an investigational targeted therapy drug designed to eliminate a key cancer-driving protein called KRAS G12D, shows encouraging early activity in patients with advanced lung and pancreatic cancers.

Brain-computer interface based on Rice research wins FDA approval for first clinical trial

Rice University
Business Announcement

Motif Neurotech, a company commercializing technology based on research at Rice, has received approval from the FDA to begin the first clinical trial of its therapeutic brain-computer interface for treatment of treatment-resistant depression.

Funder: Advanced Research Projects Agency for Health

91
92
93
94
95